Skip to main content
NCBI home page
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: J Nutr Biochem. 2017 May 25;47:113–119. doi: 10.1016/j.jnutbio.2017.05.005

The phytochemical 3,3′-Diindolylmethane decreases expression of AR-controlled DNA damage repair genes through repressive chromatin modifications and is associated with DNA damage in prostate cancer cells

Zoraya Palomera-Sanchez a, Gregory W Watson a, Carmen P Wong a,i, Laura M Beaver a,c,i, David E Williams b,c, Roderick H Dashwood d,f,g,h, Emily Ho a,c,i
PMCID: PMC5583029  NIHMSID: NIHMS882049  PMID: 28582660

Abstract

Androgen receptor (AR) is a nuclear receptor transcription factor that plays a central role in normal prostate physiology as well as in prostate cancer biology (PCa). Phytochemicals like 3,3′-Diindolylmethane (DIM) have emerged as promising therapeutic agents against PCa. DIM has been shown to influence both AR activity and other epigenetic regulators in PCa cells. However, it is not known if DIM contributes to PCa suppression via epigenetic regulation of AR target genes. Here we assessed epigenetic regulation of important AR-target genes in LNCaP PCa cells treated with DIM. DIM led to epigenetic suppression of AR-target genes involved in DNA repair (PARP1, MRE11 and DNA-PK) that coincided with an increase in DNA damage. Decreased AR-target genes expression was accompanied by an increase in repressive chromatin marks and loss of AR occupancy and recruitment of EZH2 to their regulatory regions. In addition, decreased expression of DNA repair genes was associated with an increase in DNA damage (γH2Ax) and up-regulation of genomic repeat elements LINE1 and α-satellite. Together our results suggest that the dietary phytochemical DIM suppresses AR-dependent gene transcription through epigenetic modulation, leading to DNA damage and genome instability in PCa cells.

Keywords: DIM, prostate cancer, AR, epigenetic repression, DNA damage

1. Introduction

The androgen receptor (AR) plays a critical role in prostate cancer (PCa) biology and is an important therapeutic target for cancer treatment [1,2]. In advanced PCa, AR signaling can become androgen-independent and drive aggressive cell proliferation essential for progression of castration-resistant prostatic adenocarcinoma [3]. Advancement to androgen-independent growth removes androgen deprivation therapy as a treatment option and is associated with poor outcome. Alternative strategies for antagonizing AR signaling could be useful for treatment of advanced disease.

AR regulates the expression of many genes, including a subset of those involved in responding to DNA damage when the genome is disrupted [4,5]. AR binds to specific DNA regulatory regions termed androgen response elements (AREs) and recruits chromatin modifying enzymes and transcriptional regulators to influence AR-target gene expression [6]. Recent work has shown that the histone-methyltransferase enhancer of zeste homolog 2 (EZH2) and associated proteins are recruited to ARE sites and repress AR-target gene expression in PCa [7]. This suggests that targeting the outcome of AR activity in PCa cells (i.e. AR-dependent gene regulation) by influencing chromatin-modifiers and ARE occupancy as opposed to the AR itself could be an effective strategy to slow PCa progression. Indeed, chromatin-modifiers are an attractive target for therapeutic development and several compounds have been approved for use in the clinic [8].

Epidemiological studies have shown the consumption of high levels of cruciferous vegetables, such as broccoli and Brussels sprouts, to be inversely associated with PCa risk, particularly during early stages [9,10]. 3,3′-Diindolylmethane (DIM) is a phytochemical derived from cruciferous vegetables that has been shown to induce cell-cycle arrest and apoptosis in PCa cells while sparing normal cells [11,12]. Although DIM has been shown to lead to alterations in the AR signaling pathway in PCa cells, no studies have explored a potential chromatin-dependent mechanism of action of DIM on AR-target genes.

We have previously shown that DIM treatment leads to a global decrease in histone deacetylase (HDAC) activity in PCa cells [13]. Recent work has also shown that DIM influences DNA methylation through its effect on DNA-methyltransferase (DNMT) expression, reversing some cancer-associated DNA methylation alterations involved in cancer progression [14]. Modification of local chromatin structure and promoter occupancy at ARE sties in AR-responsive genes may therefore be an as yet unappreciated contributor to PCa suppression in response to DIM treatment.

In the present study we show that DNA repair genes that are transcriptional targets of AR (AR-target DNA repair genes) are epigenetically repressed in LNCaP PCa cells following DIM treatment. Furthermore, we show an increase in chromatin marks characteristic of heterochromatin and gene silencing, which coincide with loss of AR occupancy, and recruitment of EZH2 to their regulatory regions. Decreased expression of DNA repair genes is associated with genome destabilization and an increase in DNA damage in LNCaP PCa cells.

2. Materials and methods

2.1 Cell Culture and Treatment Conditions

Human androgen-dependent prostate cancer cells (LNCaP) were obtained from American Type Culture Collection (Manassas, VA, USA). Cells were cultured in RPMI1640 media supplemented with 10% fetal bovine serum at 5% CO2 and 37°C. DIM (Sigma-Aldrich, St. Louis, MO, USA) was dissolved in dimethylsulfoxide (DMSO) with a stock concentration of 100μM. Cells were treated with a DIM dose of 15 μM and collected at 48 hours post-treatment for all experiments unless otherwise indicated. These conditions were chosen because they were previously shown to decrease cell growth, decrease HDAC activity, and cause changes in DNA methylation in LNCaP cells [11,13,14]. In addition the DIM concentration was chosen because it was physiologically attainable via supplementation [15,16].

2.2 Western blot analysis

Protein was extracted from cultured cells using RIPA-lysis buffer (50mM Tris-HCl pH8, 150mM NaCl, 1mM EDTA, 0.1% SDS, 0.5% Deoxycholate, 1% NP-40), supplemented with proteinase inhibitor cocktail (Thermo Scientific, Waltham, MA, USA). The protein extracts were quantified using the DC protein assay (BioRad, Hercules, CA, USA). For immunoblot analysis, 70μg of protein was resolved by SDS PAGE 4–12% Bis-Tris gels (Life Technologies) and blotted to PVDF membrane (BioRad) using NuPAGE reagents and equipment (Life Technologies, Carlsbad, CA, USA). Blots were blocked in 5% BSA PBS-Tween buffer for 1h. Membranes were then incubated with primary antibodies recognizing androgen receptor-D6F11 (#5153, Cell Signaling, Danvers, MA, USA), γH2Ax-Ser139 (sc:101696, Santa Cruz Biotechnology, Dallas, TX, USA), or fibrillarin-H140 (sc:25397, Santa Cruz) overnight at 4°C. Blots were then washed and incubated with goat anti-rabbit IgG-HRP as secondary antibody for detection (Santa Cruz). Protein bands were then visualized using Super Signal WestFemto Reagent Substrate (Thermo Scientific) and developed on the AlphaInnotech FluorChem 8900 system (ProteinSimple, San Jose, CA, USA). Densitometry of each specific protein band was determined using AlphaInnotech FluorChem 8900 software and normalized to its corresponding fibrillarin band.

2.3 mRNA Expression by real-time qPCR

Total RNA from treated cells was isolated using Trizol reagent (Life Technologies). cDNA was prepared with 1ug of total RNA using SuperScript III First-Strand Synthesis SuperMix for qRT-PCR (Life Technologies). The qPCR was performed using the corresponding sets of primers (Sup-Table1). Each set of primers was validated for qPCR and the slope of the standard curve for each pair of primers was −3.20 on average with a corresponding primers efficiency of 96%. Real time PCRs were done using Fast SYBR Green Mastermix (Life Technologies) on a 7900 HT Fast Real-Time PCR System (Life Technologies). Gene expression was calculated using comparative ΔΔCT method [17] in which the target gene expression of each gene was analyzed respect to the expression to the housekeeping gene GAPDH.

2.4 Chromatin Immunoprecipitation

Chromatin immunoprecipitation (ChIP) assays were done as previously described with slight modifications [14]. Briefly, treated cells were cross-linked with 1% formaldehyde for 10 min, washed three times with ice-cold PBS, harvested in SDS-lysis buffer and then the chromatin was sonicated. Protein-DNA complexes were immunoprecipitated using antibodies specific against H3K27me3 (EMD Millipore, Darmstadt, Germany), H3K4me3 (Abcam, Cambridge, MA, USA), H3K9me3 (Abcam), H3K9Ac (Abcam). Normal-IgG (Santa Cruz) was used as negative control. The complexes were recovered with protein A/G agarose beads (Life Technologies) and washed sequentially in the following buffers: RIPA, High-salt, LiCl and TE. To obtain the DNA, the washed complexes were incubated with RNAase, ProteinaseK, and then the crosslinking was reversed by incubating at 65°C over night. Finally, phenol-chloroform extraction was performed. DNA was amplified using real time PCR with the corresponding sets of primers (Sup-Table1). Each set of primers was validated for qPCR and the slope of the standard curve for each primer pair was −3.27 on average with a corresponding primers efficiency of 98%. ChIP-qPCR reactions were performed in triplicate using Fast SYBR Green Mastermix (Life Technologies). A working input DNA dilution was selected from standard curves and the CT values from the immunoprecipitated DNA was measured relative to the CT from input DNA dilution in order to get the %input [14]. ChIP assays were done in triplicate for the data analysis.

2.5 Immunofluorescence

LnCap cells grown on glass coverslips were fixed in methanol at 20’C for 10 minutes, washed three times with PBS and then incubated in 4% paraformaldehyde for 15 minutes. Cells were permeabilized with 0.4% Triton X-100 in PBS for 20 minutes and then washed twice in PBS. Samples were blocked in 5% BSA (Bovine Serum Albumin, Sigma-Aldrich) in PBS supplemented with 0.1% Igepal Ca-630 (Sigma-Aldrich) for 2 hr. Cells were probed with anti-γH2Ax phos-Ser139 antibody at 1:50 (sc-101696, Santa Cruz), then anti-rabbit IgG AlexaFluor 555 secondary antibody at 1:200 (Life Technologies). Nuclei were stained with DAPI. Coverslips were mounted in ProLog Gold (Life Technologies) and observed on a Zeiss LSM 780 NLO Confocal Microscope System. The number of γH2Ax foci per nucleus was determined using ZEN blue software from Zeiss LSM 780. One hundred and fifteen cells were analyzed for each condition in triplicate.

3. Results

3.1 DIM decreases AR-target gene expression by reducing AR-protein levels at promoters and ARE regions

Previous studies have shown that DIM down-regulates AR protein level in androgen-responsive LNCaP PCa cells [11,12,18]. We also found that AR protein levels are reduced in LNCaP cells following 15μM DIM treatment for 48h (Fig. 1A). Next, we evaluated whether a decrease in AR-protein level leads to a reduction in the expression of AR-target genes. We began by examining the well-characterized AR-target genes PSA and TMPRSS2 [3]. We also evaluated the AR-target DNA repair genes PARP1, MRE11 and DNA-PK identified in a previous AR ChIP-Seq study, in which androgen receptor signaling was shown to regulate DNA repair in PCa [4]. In particular, DNA-PK has been shown to be a key target of AR after damage, controlling AR-mediated DNA repair and cell survival after genotoxic insult [4,5]. After 48h treatment, DIM reduced the expression of the AR-target genes PSA, TMPRSS2, PARP1, MRE11 and DNA-PK (Fig. 1B). We observed no change in the expression of SAFB1, a DNA-repair gene not controlled by AR (Fig. 1B). We next examined AR protein occupancy at the promoters and AREs of these genes by chromatin immunoprecipitation (ChIP) assays and quantitative PCR (qPCR). AR levels were reduced at the promoter regions of PSA, PARP1, MRE11 and DNA-PK (Fig. 1C,D). Together these results suggest that DIM down-regulates the expression of AR-target genes, including a subset of DNA-repair genes, by reducing AR protein levels at promoters and ARE regions.

Figure 1.

Figure 1

Open in a new tab

Decreased AR-target gene expression and AR occupancy in promoters and ARE elements following DIM treatment. A) AR protein levels were analyzed by western blot in LNCaP cells treated with DIM or DMSO. Fibrillarin was probed as a loading control. B) Relative PSA, TMPRSS2, PARP1, MRE11 and DNA-PK gene expression in LNCaP cells treated with DIM or DMSO (control). PSA was assessed as a positive control (well known AR-target gene) and SAFB1 (AR-independent gene) was assessed as a negative control. Gene expression (mRNA) levels were normalized to GAPDH. C) AR ChIPs were performed after DIM or DMSO treatment in LNCaP cells and the ARE-PSA, PARP1, MRE11 promoter regions were amplified to determine AR occupancy. CCR4 promoter (AR-independent gene) was assessed as a negative control and ARE-PSA as a positive control. D) DNA-PK promoter and AREs-DNA-PK regions were amplified from AR-ChIPs. The lower diagram shows a schematic of ARE regions of DNA-PK gene. C-D) IgG (DMSO+DIM) is an average of two ChIP assays from each treatment, using Normal-IgG as negative control. Grey bars indicate positions relative to transcriptional start site of amplicons analyzed. ChIP-data are expressed as % input relative to DMSO vehicle control. In all experiments LNCaP cells were treated with 15 μM DIM or DMSO as a vehicle control for 48h. Data represents mean of three biological replicates. Graphs depict mean + standard deviation. Significance was determined by Student’s t-Test with *p<0.05, **p<0.01.

3.2 Repressive chromatin code in PSA promoter and ARE regions after DIM treatment

Chromatin modifications such as histone H3 lysine 27 trimethylation (H3K27me3), H3K9me3 and H3K4me3 play an important role in gene expression and regulation [19]. We tested whether the decrease in PSA gene expression coincides with a change in histone modifications in its proximal and distal regulatory regions. ChIP assays and qPCR were performed to examine H3K27me3, H3K9me3 and H3K4me3 levels at the PSA gene proximal promoter (−120 bp), an ARE site within the promoter (−170 bp) and the ARE-enhancer (−4162 bp) regions of PSA after 48h of DIM treatment (Fig. 2A). We found a decrease in the active mark H3K4me3 in the proximal promoter and ARE-promoter regions of the PSA gene (Fig. 2B,C). Similar decrease of H3K4me3 was observed at 24h and 72h post-DIM treatment at proximal promoter (Fig. S1b). However, we unexpectedly noted an increase in H3K4me3 at the distal ARE-enhancer region after 48h treatment (Fig. 2D). In contrast we noted an increase in the repressive chromatin marks H3K9me3 and H3K27me3 after DIM treatment in all three regulatory regions of PSA (Fig. 2B–D, Fig.S1b). Overall, our data is consistent with chromatin remodeling and gene repression following DIM treatment.

Figure 2.

Figure 2

Open in a new tab

DIM stimulates a repressive chromatin code in PSA regulatory regions. A) Schematic of AREs in the promoter and enhancer regions of PSA. Grey bars indicate positions of amplicons analyzed relative to transcriptional start site. ChIPs and qPCR assays were used to evaluate H3K4me3, H3K9me3 and H3K27me3 levels at PSA regulatory regions in LNCaP cells treated with 15 μM DIM for 48h. B) promoter (−120 bp), C) ARE-promoter (−170 bp) and D) ARE-enhancer regions of PSA gene. ChIP-data are expressed as % input compared to DMSO vehicle control. IgG (DMSO+DIM) is an average of two ChIP assays from each treatment, using Normal-IgG as negative control. Data represents three biological replicates. Graphs depict mean + standard deviation. Significance was determined by Student’s t-Test with *p<0.05, **p<0.01.

3.3 Increase in the repressive-chromatin mark H3K27me3 at the promoter region of DNA repair AR-target genes following DIM treatment

To test whether the DIM-mediated alterations in chromatin dynamics observed at the PSA promoter also occurs at the AR-target DNA repair genes [4,5], we evaluated H3K27me3 and H3K4me3 at the promoter regions of PARP1, MRE11 and DNA-PK. We observed a marked increase in H3K27me3 at the promoter region of all three genes after DIM treatment (Fig.3A–C). Interestingly, we observed no significant change in H3K4me3 after DIM treatment (Fig. 3A–C). To further confirm this repressive switch, we evaluated the repressive mark H3K9me3 at the promoter region of DNA-PK. Similar to what we observed in the PSA regulatory regions (Fig. 2), H3K9me3 was also increased at the promoter region of DNA-PK (data not shown). These results together suggest that the DIM-induced repression of AR-target DNA repair genes may occur principally via bivalent marks H3K27me3 and H3K4me3 as was observed recently with other AR-target genes [20]. In summary these results suggest that the chromatin mark H3K27me3 contributes to gene repression of DNA repair AR-target genes in response to DIM.

Figure 3.

Figure 3

Open in a new tab

Increase in repressive chromatin mark H3K27me3 at the promoter region of DNA repair AR-target genes in response to DIM. LNCaP cells were treated with 15 μM DIM or DMSO as a vehicle control for 48h. H3K27me3 and H3K4me3 levels were assessed by ChIP in the promoters of A) PARP1, B) MRE11 and C) DNA-PK. H3K9me3 levels following DIM treatment were also assessed in the DNA-PK promoter. IgG (DMSO+DIM) is an average of two ChIP assays from each treatment, using Normal-IgG as negative control ChIP-data are expressed as % input relative to DMSO vehicle control. Data represents three biological replicates. Graphs depict mean + standard deviation. Significance was determined by Student’s t-Test with *p<0.05, **p<0.01.

3.4 Increase in EZH2 occupancy at DNA repair AR-target genes following DIM treatment

The repressive histone mark H3K27me3 is catalyzed by the histone-methyltransferase EZH2, a constituent of the polycomb repressive complex 2 (PRC2) [21]. Interestingly, recent work has shown that EZH2 and associated proteins are recruited to PSA-ARE promoter site and affect its expression in PCa [7]. We next tested whether DIM leads to recruitment of EZH2 to the promoter regions of our AR-target genes of interest. We found a significant increase in the recruitment of EZH2 at the PSA-ARE promoter, PSA-ARE enhancer, as well as at the promoter regions of DNA-PK, MRE11 and PARP1 genes (Fig. 4). DIM may therefore suppress DNA repair AR-target genes through recruitment of polycomb repressive chromatin proteins to their gene regulatory regions.

Figure 4.

Figure 4

Open in a new tab

Increased EZH2 at the promoter region of PSA and DNA repair AR-target genes following DIM treatment. LNCaP cells were treated with 15 μM DIM or DMSO as a vehicle control for 48h. EZH2 ChIPs were performed after treatment and the ARE-promoter PSA (PSA.ARE promoter), ARE-enhancer PSA (PSA.ARE enhancer), DNA-PK, MRE11 and PARP1 promoter regions were amplified by qPCR. ChIP-data are expressed as % input relative to DMSO vehicle control. PSA.ARE promoter was evaluated as a positive control; GAPDH and CYR61 (non AR targets genes) were evaluated as negative controls. IgG (DMSO+DIM) is an average of two ChIP assays from each treatment, using Normal-IgG as negative control. Data represents three biological replicates. Graphs depict mean + standard deviation. Significance was determined by Student’s t-Test with *p<0.05.

3.5 DIM treatment causes an increase in the DNA damage in LNCaP cells

DIM increases DNA damage by inducing double strand breaks (DSB) in colon cancer cells [22]. To test whether the observed down-regulation of DNA repair genes (DNA-PK, MRE11 and PARP1) following DIM treatment leads to an increase in DNA damage in LNCaP PCa cells, we analyzed phosphorylated-H2Ax (γH2Ax) as a marker of DSB and genome instability [23]. We noted a concentration-dependent increase in γH2Ax in LNCaP cells treated with DIM for 48h (Fig. 5A). Analysis of γH2Ax by confocal microscopy also revealed a significant increase in the number of γH2Ax foci per cell (Fig. 5B). Previous studies have drawn a proportional relation between the number of γH2Ax foci to the retrotransposition frequency and increased expression of repeat elements such as LINE1 by oxidative stress and irradiation [24,25]. Since it is known that DIM produced oxidative stress in different cancer cells [22,26], we next tested whether the increase in γH2Ax foci by DIM leads to a change in LINE1 and peri-centric heterochromatin repeat sequence (α-satellite) expression in LNCap cells. We found that the expression of both repeat sequences were up-regulated after DIM treatment in a concentration-dependent manner (Fig. 5C). Altogether, these results suggest that the down-regulation of DNA repair AR-target genes after DIM treatment leads to an increase in DSB DNA damage and possible genome instability in LNCaP cells.

Figure 5.

Figure 5

Open in a new tab

Decreased gene expression of AR-target DNA repair genes after DIM treatment is associated with an increase in DNA double strand breaks (DSBs). A) Western blot assays were used to analyze the global levels of γH2Ax in LNCaP cells treated with the indicated concentrations of DIM for 48h. DMSO was used as vehicle control. Fibrillarin was probed as a loading control. Graph depicts mean + standard deviation for five independent experiments. Significance was determined by Student’s t-Test with *p<0.05. B) LNCaP cells were treated with 15 μM DIM or DMSO as a vehicle control for 48h. The number of γH2Ax foci per cell were counted for 115 cells per condition in three independent biological experiments. Red: γH2Ax, Blue: DAPI. Graph depicts mean + standard deviation. Significance was determined by Student’s t-Test with *p<0.05, **p<0.01. C) Relative expression of transposable element LINE1 and pericentromeric α-satellite repeat normalized to GAPDH expression in LNCaP cells treated with the indicated concentrations of DIM or DMSO for 48h. All Graphs depict mean + standard deviation for three to five independent experiments. Significance was determined by Student’s t-Test with *p<0.05, **p<0.01.

4. Discussion

Epigenetic plasticity has been intensely studied in cancer biology and has led to the identification of new molecular targets against cancer [8]. Indeed, dietary phytochemicals such as DIM impact important epigenetic processes in cancer cells, making them attractive compounds for therapeutic development. Previous work in our lab showed that DIM decreases global HDAC activity in LNCaP cells [13]. Furthermore, we recently showed that DIM can influence DNA methylation in prostate cancer cells [14]. These studies suggest that altered chromatin dynamics may contribute to cell-cycle arrest and induction of apoptosis in response to DIM in PCa cells [11,12,18].

In the present work we observed a decrease of AR protein level after DIM treatment (Fig.1), which has been previously reported [11,12,18]. Interestingly, despite a decrease in protein level, AR expression was up-regulated with no significant change in chromatin modifications at its promoter region (Fig. S2). This suggests AR-protein instability following treatment. Further work will be needed to characterize how DIM treatment results in AR turnover.

A decrease in PSA expression in response to DIM has been characterized and is reflective of a decrease in AR protein [12,18]. Our results similarly observed a decrease in PSA gene expression after DIM treatment (Fig. 1, Fig.S1a). Importantly, we also observed decreased expression of a subset of AR-target DNA repair genes PARP1, MRE11 and DNA-PK following DIM treatment and are the first to show depletion of AR from regulatory cis elements at their promoters (Fig. 1C–D). Many studies have characterized the connection between chromatin modifications such as histone methylation (H3K9me3, H3K27me3, H3K4me3) and transcriptional regulation [19]. More specifically, previous studies have reported that H3K27me3 and H3K4me3 play a key role in transcriptional regulation of AR-target genes [7,20]. We found that down-regulation of PSA expression after DIM treatment correlated with an increase in repressive-chromatin marks H3K9me3 and H3K27me3 and a decrease in the open mark H3K4me3 at its regulatory regions (proximal-promoter and ARE-promoter) (Fig. 2). Our results also suggest that the down-regulated expression of the DNA repair AR-target genes PARP1, MRE11 and DNA-PK after DIM treatment is associated principally with the gene repression mark H3K27me3 at their promoter regions (Fig.3).

Another important discovery of this present study is that DIM leads to an increase in the binding of EZH2 to promoter regions of these DNA repair AR-target genes that correlates with an increase in H3K27me3 and a decrease in their gene expression (Fig. 4). This is consistent with previous findings that show that EZH2 can act as a transcriptional repressor of AR-target genes [7,20]. Further work will be needed to identify the full complement of proteins that participate in AR-target gene repression in response to DIM and could identify new protein targets for therapeutic development.

DIM-induced recruitment of EZH2 to the regulatory regions of the DNA repair genes was associated with their decreased expression and an increase in global and local DNA damage as indicated by increased γH2Ax levels (Fig. 5A–B). In addition, we also noted an increase in the expression of the LINE1 and α-satellite repeat elements that are indicators of genome instability in response to stress. Together these data suggest a novel mechanism of action by which DIM interferes with AR signaling via DNA repair in LNCap PCa cells: epigenetic repression of AR-target DNA repair genes that leads to DNA damage and genome instability. DIM has been shown by our group and others to affect multiple epigenetic processes. Further work characterizing how DIM influences the timing and coordination of different epigenetic responses will provide a fuller understanding of why this dietary phytochemical is an effective agent in suppressing PCa growth.

Supplementary Material

1
2
3

Acknowledgments

We thank Concejo Nacional de Ciencia y Tecnología (CONACYT) for the postdoctoral fellowship # 235093. This study was supported Center for Genome Research and Biocomputing (CGRB) Core Facilities, Oregon Agricultural Experimental Station, as well as the National Cancer Institute (P01 CA090890) and National Institute of Environmental Health Sciences (P30 ES000210). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

We also thank Anne-Marie Girard for help with the confocal Zeiss LSM 780 microscope training at CGRB of Oregon State University and the NFS award # 1337774 for acquisition of Confocal and Two-Photon Excitation Microscope.

Abbreviations

AR

androgen receptor

DIM

3,3′-Diindolylmethane

ARE

androgen response element

PSA

prostate specific antigen

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Conflict of Interest

The authors declare no conflict of interest.

References

  • 1.Taplin M-E. Drug Insight: role of the androgen receptor in the development and progression of prostate cancer. Nat Clin Prac Oncol. 2007;4:236–44. doi: 10.1038/ncponc0765. [DOI] [PubMed] [Google Scholar]
  • 2.Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med. 2003;10:33–9. doi: 10.1038/nm972. [DOI] [PubMed] [Google Scholar]
  • 3.Mills IG. Maintaining and reprogramming genomic androgen receptor activity in prostate cancer. Nature Publishing Group. 2014:1–13. doi: 10.1038/nrc3678. [DOI] [PubMed] [Google Scholar]
  • 4.Polkinghorn WR, Parker JS, Lee MX, Kass EM, Spratt DE, Iaquinta PJ, et al. Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers. Cancer Discovery. 2013;3:1245–53. doi: 10.1158/2159-8290.CD-13-0172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Goodwin JF, Schiewer MJ, Dean JL, Schrecengost RS, de Leeuw R, Han S, et al. A Hormone-DNA Repair Circuit Governs the Response to Genotoxic Insult. Cancer Discovery. 2013;3:1254–71. doi: 10.1158/2159-8290.CD-13-0108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Wang Q, Carroll JS, Brown M. Spatial and Temporal Recruitment of Androgen Receptor and Its Coactivators Involves Chromosomal Looping and Polymerase Tracking. Molecular Cell. 2005;19:631–42. doi: 10.1016/j.molcel.2005.07.018. [DOI] [PubMed] [Google Scholar]
  • 7.Mukhopadhyay NK, Kim J, You S, Morello M, Hager MH, Huang W-C, et al. Scaffold attachment factor B1 regulates the androgen receptor in concert with the growth inhibitory kinase MST1 and the methyltransferase EZH2. Oncogene. 2013;33:3235–45. doi: 10.1038/onc.2013.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Dawson MA, Kouzarides T. Cancer Epigenetics:From Mechanism to Therapy. Cell. 2012;150:12–27. doi: 10.1016/j.cell.2012.06.013. [DOI] [PubMed] [Google Scholar]
  • 9.Gerhäuser C. Epigenetic impact of dietary isothiocyanates in cancer chemoprevention. Current Opinion in Clinical Nutrition and Metabolic Care. 2013;16:405–10. doi: 10.1097/MCO.0b013e328362014e. [DOI] [PubMed] [Google Scholar]
  • 10.Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC. A prospective study of cruciferous vegetables and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:1403–9. [PubMed] [Google Scholar]
  • 11.Le HT, Schaldach CM, Firestone GL, Bjeldanes LF. Plant-derived 3,3′-Diindolylmethane Is a Strong Androgen Antagonist in Human Prostate Cancer Cells. Journal of Biological Chemistry. 2003;278:21136–45. doi: 10.1074/jbc.M300588200. [DOI] [PubMed] [Google Scholar]
  • 12.Bhuiyan MMR, Li Y, Banerjee S, Ahmed F, Wang Z, Ali S, et al. Down-regulation of Androgen Receptor by 3,3′-Diindolylmethane Contributes to Inhibition of Cell Proliferation and Induction of Apoptosis in Both Hormone-Sensitive LNCaP and Insensitive C4-2B Prostate Cancer Cells. Cancer Research. 2006;66:10064–72. doi: 10.1158/0008-5472.CAN-06-2011. [DOI] [PubMed] [Google Scholar]
  • 13.Beaver LM, Yu T-W, Sokolowski EI, Williams DE, Dashwood RH, Ho E. 3,3′-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells. Toxicology and Applied Pharmacology. 2012;263:345–51. doi: 10.1016/j.taap.2012.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Wong CP, Hsu A, Buchanan A, Palomera Sanchez Z, Beaver LM, Houseman EA, et al. Effects of Sulforaphane and 3,3′-Diindolylmethane on Genome-Wide Promoter Methylation in Normal Prostate Epithelial Cells and Prostate Cancer Cells. PLoS ONE. 2014;9:e86787–13. doi: 10.1371/journal.pone.0086787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Anderton MJ, Manson MM, Verschoyle RD, Gescher A, Lamb JH, Farmer PB, et al. Pharmacokinetics and Tissue Disposition of Indole-3-carbinol and Its Acid Condensation Products after Oral Administrationto Mice. Clinical Cancer Research. 2004;10:5233–41. doi: 10.1158/1078-0432.CCR-04-0163. [DOI] [PubMed] [Google Scholar]
  • 16.Stresser DM, et al. Mechanisms of tumor modulation by indole-3-carbinol Disposition and excretion in male Fischer 344 rats. Drug Metabolism and Disposition. 1995 Sep;23(9):965–975. 2005: 1–11. [PubMed] [Google Scholar]
  • 17.Schmittgen TD, Livak KJ. Analyzing real time PCR data by the comparative CT method. Nature Protocols. 2008:1–8. doi: 10.1038/nprot.2008.73. [DOI] [PubMed] [Google Scholar]
  • 18.Chen D, Banerjee S, Cui QC, Kong D, Sarkar FH, Dou QP. Activation of AMP-Activated Protein Kinase by 3,3′-Diindolylmethane (DIM) Is Associated with Human Prostate Cancer Cell Death In Vitro and In Vivo. PLoS ONE. 2012;7:e47186–7. doi: 10.1371/journal.pone.0047186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Zentner GE, Henikoff S. Regulation of nucleosome dynamics by histone modifications. Nature Publishing Group. 2013;20:259–66. doi: 10.1038/nsmb.2470. [DOI] [PubMed] [Google Scholar]
  • 20.Zhao JC, Yu J, Runkle C, Wu L, Hu M, Wu D, et al. Cooperation between Polycomb and androgen receptor during oncogenic transformation. Genome Research. 2012;22:322–31. doi: 10.1101/gr.131508.111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.van Kruijsbergen I, Hontelez S, Veenstra GJC. Recruiting polycomb to chromatin. International Journal of Biochemistry and Cell Biology. 2015;67:177–87. doi: 10.1016/j.biocel.2015.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Li Y, Li X, Guo B. Chemopreventive Agent 3,3′-Diindolylmethane Selectively Induces Proteasomal Degradation of Class I Histone Deacetylases. Cancer Research. 2010;70:646–54. doi: 10.1158/0008-5472.CAN-09-1924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Valdiglesias V, Giunta S, Fenech M, Neri M, Bonassi S. γH2AX as a marker of DNA double strand breaks and genomic instability in human population studies. Mutation Research-Reviews in Mutation Research. 2013;753:24–40. doi: 10.1016/j.mrrev.2013.02.001. [DOI] [PubMed] [Google Scholar]
  • 24.Farkash EA. Gamma radiation increases endonuclease-dependent L1 retrotransposition in a cultured cell assay. Nucleic Acids Research. 2006;34:1196–204. doi: 10.1093/nar/gkj522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Giorgi G, Marcantonio P, Del Re B. LINE-1 retrotransposition in human neuroblastoma cells is affected by oxidative stress. Cell Tissue Res. 2011;346:383–91. doi: 10.1007/s00441-011-1289-0. [DOI] [PubMed] [Google Scholar]
  • 26.Gong Y. 3,3′-Diindolylmethane Is a Novel Mitochondrial H+-ATP Synthase Inhibitor that Can Induce p21Cip1/Waf1 Expression by Induction of Oxidative Stress in Human Breast Cancer Cells. Cancer Research. 2006;66:4880–7. doi: 10.1158/0008-5472.CAN-05-4162. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1
NIHMS882049-supplement-1.docx (84.2KB, docx)
2
NIHMS882049-supplement-2.tiff (1.5MB, tiff)
3
NIHMS882049-supplement-3.tiff (1.5MB, tiff)

RESOURCES